Related Experiment Video
Updated: Feb 10, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Persistent and progressive long-term lung disease in survivors of preterm birth
Rhea Urs1, Sailesh Kotecha2, Graham L Hall1
1Telethon Kids Institute, Perth, Australia; School of Physiotherapy and Exercise Science, Faculty of Health Sciences, Curtin University, Perth, Australia.
Insights
Preterm birth survivors face long-term respiratory issues, including chronic lung disease (bronchopulmonary dysplasia). This review explores the persistent pulmonary problems and potential treatments for these infants.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Respiratory Medicine
Background:
- Preterm birth affects 11% of global births, with rising rates in many countries.
- Neonatal care advances improve survival for infants born at lower gestational ages (GA).
- Infants born <32 weeks GA often experience adverse respiratory outcomes and increased healthcare use into childhood.
Purpose of the Study:
- To review the long-term pulmonary outcomes in contemporary preterm infants.
- To examine the mechanisms contributing to long-term respiratory morbidity.
- To discuss knowledge gaps and potential targeted treatments for respiratory complications.
Main Methods:
- Literature review of contemporary research on preterm birth and long-term respiratory outcomes.
- Analysis of studies investigating the mechanisms of persistent lung disease.
- Synthesis of information on current and potential therapeutic strategies.
Main Results:
- Preterm infants, especially those with bronchopulmonary dysplasia (BPD), exhibit increased respiratory symptoms and hospitalizations.
- Altered lung structure and persistent, sometimes declining, lung function are observed throughout childhood and into adulthood.
- The underlying mechanisms for progressive lung disease in preterm survivors remain unclear.
Conclusions:
- Preterm birth leads to significant long-term respiratory morbidity, impacting lung health into adulthood.
- Understanding the mechanisms of persistent lung disease is crucial for developing effective interventions.
- Further research and targeted treatments are needed to improve respiratory outcomes for preterm survivors.
Abstract:
Preterm birth accounts for approximately 11% of births globally, with rates increasing across many countries. Concurrent advances in neonatal care have led to increased survival of infants of lower gestational age (GA). However, infants born <32 weeks of GA experience adverse respiratory outcomes, manifesting with increased respiratory symptoms, hospitalisation and health care utilisation into early childhood. The development of bronchopulmonary dysplasia (BPD) - the chronic lung disease of prematurity - further increases the risk of poor respiratory outcomes throughout childhood, into adolescence and adulthood. Indeed, survivors of preterm birth have shown increased respiratory symptoms, altered lung structure, persistent and even declining lung function throughout childhood. The mechanisms behind this persistent and sometimes progressive lung disease are unclear, and the implications place those born preterm at increased risk of respiratory morbidity into adulthood. This review aims to summarise what is known about the long-term pulmonary outcomes of contemporary preterm birth, examine the possible mechanisms of long-term respiratory morbidity in those born preterm and discuss addressing the unknowns and potentials for targeted treatments.
More Related Videos
05:11Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
Published on: May 10, 2024
08:58Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Related Concept Videos
Birth Control Methods
Lung Capacity
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Long-term Potentiation